Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels |
| |
| Authors: | Anne Caufriez,André s Tabernilla,Raf Van Campenhout,Axelle Cooreman,Kaat Leroy,Julen Sanz Serrano,Prashant Kadam,Bruna dos Santos Rodrigues,Arthur Lamouroux,Steven Ballet,Mathieu Vinken |
| |
| Affiliation: | 1.Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium; (A.C.); (A.T.); (R.V.C.); (A.C.); (K.L.); (J.S.S.); (P.K.); (B.d.S.R.);2.Departments of Chemistry and Bioengineering Sciences, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium; (A.L.); (S.B.) |
| |
| Abstract: | |
| |
| Keywords: | COVID-19 antiviral and anti-inflammatory drugs pannexin1 |
|
|
